Skip to Main Content

Meet Dr. Stephanie Halene

March 17, 2022

Meet Dr. Stephanie Halene

 .
  • 00:00I'm Stephanie Helena.
  • 00:01I am associate professor of
  • 00:03hematology and internal medicine.
  • 00:05And I'm the chief of hematology,
  • 00:08and I focus on Mallard display.
  • 00:10JE and acute myeloid leukemia.
  • 00:12To me, the most important thing is
  • 00:15to build a team that seamlessly
  • 00:17transitioned from the clinic all
  • 00:20the way to basic science that
  • 00:22brings questions from the clinic
  • 00:24to the basic science laboratories,
  • 00:27and that brings innovation from the basic
  • 00:30science laboratories back to the patient.
  • 00:32Advancements in in medicine.
  • 00:34A general in hematology have been.
  • 00:36Absolutely amazing and we are in a
  • 00:39phenomenal time for for innovation.
  • 00:41I think a lot of it comes from our
  • 00:45deeper understanding of diseases.
  • 00:47We have so many technologies at our
  • 00:50fingertips to understand what causes disease,
  • 00:53what drives disease,
  • 00:54what results in resistance is to therapies,
  • 00:57and as a result we can develop novel
  • 01:01therapies that we never had the
  • 01:03opportunity to do that are no longer these.
  • 01:07Sledge hammer chemotherapies but very
  • 01:09targeted at what drives the cancer.
  • 01:12One area that my laboratory is
  • 01:15particularly interested in is how
  • 01:17RNA modifications and we look
  • 01:20at how this RNA is altered,
  • 01:22for example through mutations and so
  • 01:25called splicing factors or through
  • 01:28abnormalities and RNA editing.
  • 01:30And we have identified a couple
  • 01:33of mechanisms in that area that
  • 01:35we may be able to exploit in the
  • 01:38therapy of hematologic diseases.